Clinical Research Associates, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Nashville TN United States (1989)

Organization Overview

First Clinical Trial
2005
NCT00293657
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clinical Research Associates, Inc. | Clinical Research Associates, Inc., Nashville, TN 37203 | Clinical Research Associates, LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

paroxetine (paxil) (1 trial)

Drugs in Phase 2 Trials (4)

anthrax vaccine, adsorbed (Biothrax) (1 trial)

arbaclofen (2 trials)

lornoxicam (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anthrax (Phase 2)

Autistic Disorder (Phase 1)

Headache (Phase 2)

Hot Flashes (Phase 3)

Migraine Disorders (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5